Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?

Shankar, Abhishek; Saini, Deepak; Richa, .; Goyal, Nalin; Roy, S. C. Dutta; Angural, Harpreet; Kaushal, Vikrant; Bharati, Sachidanand Jee; Upadhyaya, Rituraj; Durga, T.

doi:10.4103/apjon.apjon_57_20

Cited by 12 publications

(13 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Upon abstract screening, 893 articles were excluded due to unrelated research topics, failing to complete inclusion criteria, or not being published in English. Then, 14 full-text articles were assessed, of which 06 articles qualified for inclusion criteria of the study [ 12 - 17 ] (Table 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…Most studies were published in 2020. Included studies were conducted by New Delhi (n=4) [ 12 , 15 - 17 ], followed by other tertiary cancer care institutions (n=2) [ 13 , 14 ] in India. The majority of the studies were review articles [ 13 , 16 ], followed by observational studies [ 14 , 15 ], editorial articles [ 12 ], and guidelines by IAPC [ 17 ].…”

Section: Resultsmentioning

confidence: 99%

“…Included studies were conducted by New Delhi (n=4) [ 12 , 15 - 17 ], followed by other tertiary cancer care institutions (n=2) [ 13 , 14 ] in India. The majority of the studies were review articles [ 13 , 16 ], followed by observational studies [ 14 , 15 ], editorial articles [ 12 ], and guidelines by IAPC [ 17 ]. Most of the included studies were conducted on either cancer patients [ 12 , 13 , 15 , 16 ], advanced cancer patients [ 17 ], or health care workers [ 14 ].…”

Section: Resultsmentioning

confidence: 99%

“…The majority of the studies were review articles [ 13 , 16 ], followed by observational studies [ 14 , 15 ], editorial articles [ 12 ], and guidelines by IAPC [ 17 ]. Most of the included studies were conducted on either cancer patients [ 12 , 13 , 15 , 16 ], advanced cancer patients [ 17 ], or health care workers [ 14 ].…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review

Rohilla¹,

Kalyani²,

Gupta³

et al. 2021

CPEMH

View full text Add to dashboard Cite

Background: The recent pandemic of COVID-19 caused havoc on the health system globally and raised a lot of questions and issues. Treatment for cancer is an emergency that cannot be taken back, particularly in an era of global pandemics. Cancer treatment mainly includes chemotherapy, surgery, radiotherapy, and palliative care, and because of the pandemic, all of these treatments are affected. The COVID-19 pandemic also had a potential effect on the quality of life and mental health of patients as well as health workers. Objective: This systematic review was intended to discuss the quality of life of people with cancer in the era of the COVID-19 pandemic in India in the light of the best available facts. Methods: An extensive literature search was done on PubMed, Medline, Embase, Clinical Key and Google Scholar databases till 3rd Feb 2021. Out of 1455 research articles, 06 research articles were included in this systematic review. Results: The results showed that cancer treatment delivery was as per standard safety protocol and the best treatment decisions were made by scheduling and setting priority. Till data, no direct research was conducted on the Indian continent to assess the quality of life of cancer patients in the COVID-19 era. The effect on the quality of life of cancer patients is very large and needs to be explored more by further research. Issues to be discussed with health care administrators and policy makers further. The tele-oncology method of cancer care delivery to patients is another rational option which is applicable as well. Conclusion: This systematic review demonstrated up-to-date evidence regarding the quality of life of cancer patients in the COVID-19 era in India. No research has been done to assess the quality of life of cancer patients. Still, the area is unrevealed, but evidence from other global studies indicates an altered quality of life for cancer patients. To maintain quality of life, cancer physicians should make evidence-based decisions and incorporate multidisciplinary management into decision making.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review

Rohilla¹,

Kalyani²,

Gupta³

et al. 2021

CPEMH

View full text Add to dashboard Cite

show abstract

“…Most of these women present in advanced stages and require multi-modal cancer therapy, which extends over months involving surgery and chemotherapy [ 1 ]. It has been recognized that the coronavirus disease 2019 (COVID-19) pandemic has disrupted cancer care delivery [ 2 ], [ 3 ]. The impact has been due to two reasons: there has been a partial or complete shutdown of non-covid services in hospitals due to the overwhelming load of patients with COVID-19 illness and the “lockdown,” which was essential to control the spread of infection in society, affecting the movement of patients to the hospital [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer

et al. 2021

View full text Add to dashboard Cite

The covid-19 pandemic has impacted the management of non-covid-19 illnesses. Epithelial ovarian cancer (EOC) requires long-duration multidisciplinary treatment. Teleconsultation and shared care are suggested solutions to mitigate the consequences of the pandemic. However, these may be challenging to implement among patients who come from the lower economic strata. We report the disastrous impact of the pandemic on the care of EOC by comparing patients who were treated during the pandemic with those treated in the previous year. We collected the following data from newly diagnosed patients with EOC: time from diagnosis to treatment, time for completion of planned chemotherapy, and proportion of patients completing various components of therapy (surgery and chemotherapy). Patients treated between January 2019 and September 2019 (Group 1: Pre-covid) were compared with those treated between January 2020 and December 2020 (Group 2: During covid pandemic). A total of 82 patients were registered [Group 1: 43(51%) Group 2: 39(49)]. The median time from diagnosis to start of treatment was longer in group 2 when compared to group 1 [31(23–58) days versus 17(11–30) days ( p = 0.03)]. The proportion of patients who had surgery in group 2 was lower in comparison to group 1 [33(77%) versus 21(54%) ( p = 0.02)]. Proportion of patients who underwent neoadjuvant (NACT) and surgery were fewer in group 2 in comparison to group 1 [9(33%) versus 18(64%) p = 0.002]. Among patients planned for adjuvant chemotherapy, the median time from diagnosis to treatment was longer in group 2 [28(17–45) days, group 1 versus 49(26–78) days, group 2 ( p = 0.04)]. The treatment of patients with EOC was adversely impacted due to the COVID-19 pandemic. There was a compromise in the proportion of patients completing planned therapy. Even among those who completed the treatment, there were considerable delays when compared with the pre-covid period. The impact of these compromises on the outcomes will be known with longer follow-up.

show abstract

Outcomes of Patients Undergoing Major Surgery for Cancer with COVID-19 in the Postoperative Period

Das¹,

Talukdar²,

Bhutia³

et al. 2023

Indian J Surg Oncol

View full text Add to dashboard Cite

Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?

Cited by 12 publications

References 9 publications

Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review

Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review

The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer

Outcomes of Patients Undergoing Major Surgery for Cancer with COVID-19 in the Postoperative Period

Contact Info

Product

Resources

About